You are viewing the site in preview mode
Skip to main content
|
Variables (n = 1116)
|
n (%)
|
|---|
|
Glucocorticoids
|
529 (47.4)
|
|
Dose ≥10 mg (n = 527)
|
82/527 (15.6)
|
|
Non-steroidal anti-inflammatory
|
743 (66.6)
|
|
Methotrexate
|
742 (66.5)
|
|
Leflunomide
|
378 (33.9)
|
|
Antimalarials (chloroquine/hydroxychloroquine)
|
146 (13.1)
|
|
Sulfasalazine
|
55 (4.9)
|
|
Tofacitinib
|
9 (0.8)
|
|
Biologicals
|
398 (35.7)
|
|
Anti-TNF (adalimumab, infliximab, etanercept, certolizumab, golimumab)
|
222 (19.9)
|
|
Anti-IL6r (tocilizumab)
|
55 (4.9)
|
|
Abatacept
|
72 (6.5)
|
|
Rituximab
|
49 (4.4)
|
